Skip to main content
All lobbying filings

NOVEL STRATEGIES (FKA) PRISM GROUP

Lobbying for THE ALLIANCE FOR LONGEVITY INITIATIVES · Advancing policies to increase a healthy human lifespan.

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Income
$20,000.00
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Directing the Food and Drug Administration to create a pathway for longevity treatment. Reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health.

Budget/Appropriations

Increased funding for longevity research at the National Institutes of Health

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem